Autosomal recessive Alport syndrome: An in-depth clinical and molecular analysis of five families

Ilaria Longo, Elisa Scala, Francesca Mari, Rossella Caselli, Chiara Pescucci, Maria Antonietta Mencarelli, Caterina Speciale, Marisa Giani, Elena Bresin, Domenica Angela Caringella, Zvi U. Borochowitz, Komudi Siriwardena, Ingrid Winship, Alessandra Renieri, Ilaria Meloni

Research output: Contribution to journalArticle

Abstract

Background. Alport syndrome (ATS) is a progressive inherited nephropathy characterized by irregular thinning, thickening and splitting of the glomerular basement membrane (GBM) often associated with hearing loss and ocular symptoms. ATS has been shown to be caused by COL4A5 mutations in its X-linked form and by COL4A3 and COL4A4 mutations in its autosomal forms. Methods. Five families with a suspicion of ATS were investigated both from a clinical and molecular point of view. COL4A3 and COL4A4 genes were analysed by DHPLC. Automated sequencing was performed to identify the underlying mutation. Results. Molecular analysis indicated that in all 5 cases the correct diagnosis was autosomal recessive ATS. In three families in which parental consanguinity clearly pinpointed to autosomal recessive ATS, we found COL4A4 homozygous mutations in two of them and COL4A3 homozygous mutation in the other one. In the remaining two families a differential diagnosis including X-linked ATS, autosomal recessive ATS and thin basement membrane nephropathy was considered. The molecular analysis demonstrated that the probands were genetic compounds for two different mutations in the COL4A4 gene pinpointing to the correct diagnosis of autosomal recessive ATS. Conclusions. A clinical evaluation of probands and their relatives of the five families carrying mutations in either the COL4A3 or the COL4A4 gene was carried out to underline the natural history of the autosomal recessive ATS. In addition, this paper stresses the complexity of the clinics and genetics of ATS and how a correct diagnosis is based on a combination of: (i) an in-depth clinical investigation; (ii) a detailed formal genetic analysis; (iii) a correct technical choice of the gene to be investigated; (iv) a correct technical choice of the family member to be included in the mutational screening. A correct diagnosis is the basis for an appropriate genetic counselling dealing with both the correct prognosis and the accurate recurrence risk for the patients and family members.

Original languageEnglish
Pages (from-to)665-671
Number of pages7
JournalNephrology Dialysis Transplantation
Volume21
Issue number3
DOIs
Publication statusPublished - Mar 2006

Fingerprint

Hereditary Nephritis
Mutation
Genes
Consanguinity
Glomerular Basement Membrane
Genetic Counseling
Hearing Loss
Differential Diagnosis

Keywords

  • Autosomal recessive ATS
  • Collagen IV genes
  • DHPLC
  • Inherited nephropathy
  • Phenotypic variability

ASJC Scopus subject areas

  • Nephrology
  • Transplantation

Cite this

Longo, I., Scala, E., Mari, F., Caselli, R., Pescucci, C., Mencarelli, M. A., ... Meloni, I. (2006). Autosomal recessive Alport syndrome: An in-depth clinical and molecular analysis of five families. Nephrology Dialysis Transplantation, 21(3), 665-671. https://doi.org/10.1093/ndt/gfi312

Autosomal recessive Alport syndrome : An in-depth clinical and molecular analysis of five families. / Longo, Ilaria; Scala, Elisa; Mari, Francesca; Caselli, Rossella; Pescucci, Chiara; Mencarelli, Maria Antonietta; Speciale, Caterina; Giani, Marisa; Bresin, Elena; Caringella, Domenica Angela; Borochowitz, Zvi U.; Siriwardena, Komudi; Winship, Ingrid; Renieri, Alessandra; Meloni, Ilaria.

In: Nephrology Dialysis Transplantation, Vol. 21, No. 3, 03.2006, p. 665-671.

Research output: Contribution to journalArticle

Longo, I, Scala, E, Mari, F, Caselli, R, Pescucci, C, Mencarelli, MA, Speciale, C, Giani, M, Bresin, E, Caringella, DA, Borochowitz, ZU, Siriwardena, K, Winship, I, Renieri, A & Meloni, I 2006, 'Autosomal recessive Alport syndrome: An in-depth clinical and molecular analysis of five families', Nephrology Dialysis Transplantation, vol. 21, no. 3, pp. 665-671. https://doi.org/10.1093/ndt/gfi312
Longo, Ilaria ; Scala, Elisa ; Mari, Francesca ; Caselli, Rossella ; Pescucci, Chiara ; Mencarelli, Maria Antonietta ; Speciale, Caterina ; Giani, Marisa ; Bresin, Elena ; Caringella, Domenica Angela ; Borochowitz, Zvi U. ; Siriwardena, Komudi ; Winship, Ingrid ; Renieri, Alessandra ; Meloni, Ilaria. / Autosomal recessive Alport syndrome : An in-depth clinical and molecular analysis of five families. In: Nephrology Dialysis Transplantation. 2006 ; Vol. 21, No. 3. pp. 665-671.
@article{2cb79492eb5e4314a916b161364e61af,
title = "Autosomal recessive Alport syndrome: An in-depth clinical and molecular analysis of five families",
abstract = "Background. Alport syndrome (ATS) is a progressive inherited nephropathy characterized by irregular thinning, thickening and splitting of the glomerular basement membrane (GBM) often associated with hearing loss and ocular symptoms. ATS has been shown to be caused by COL4A5 mutations in its X-linked form and by COL4A3 and COL4A4 mutations in its autosomal forms. Methods. Five families with a suspicion of ATS were investigated both from a clinical and molecular point of view. COL4A3 and COL4A4 genes were analysed by DHPLC. Automated sequencing was performed to identify the underlying mutation. Results. Molecular analysis indicated that in all 5 cases the correct diagnosis was autosomal recessive ATS. In three families in which parental consanguinity clearly pinpointed to autosomal recessive ATS, we found COL4A4 homozygous mutations in two of them and COL4A3 homozygous mutation in the other one. In the remaining two families a differential diagnosis including X-linked ATS, autosomal recessive ATS and thin basement membrane nephropathy was considered. The molecular analysis demonstrated that the probands were genetic compounds for two different mutations in the COL4A4 gene pinpointing to the correct diagnosis of autosomal recessive ATS. Conclusions. A clinical evaluation of probands and their relatives of the five families carrying mutations in either the COL4A3 or the COL4A4 gene was carried out to underline the natural history of the autosomal recessive ATS. In addition, this paper stresses the complexity of the clinics and genetics of ATS and how a correct diagnosis is based on a combination of: (i) an in-depth clinical investigation; (ii) a detailed formal genetic analysis; (iii) a correct technical choice of the gene to be investigated; (iv) a correct technical choice of the family member to be included in the mutational screening. A correct diagnosis is the basis for an appropriate genetic counselling dealing with both the correct prognosis and the accurate recurrence risk for the patients and family members.",
keywords = "Autosomal recessive ATS, Collagen IV genes, DHPLC, Inherited nephropathy, Phenotypic variability",
author = "Ilaria Longo and Elisa Scala and Francesca Mari and Rossella Caselli and Chiara Pescucci and Mencarelli, {Maria Antonietta} and Caterina Speciale and Marisa Giani and Elena Bresin and Caringella, {Domenica Angela} and Borochowitz, {Zvi U.} and Komudi Siriwardena and Ingrid Winship and Alessandra Renieri and Ilaria Meloni",
year = "2006",
month = "3",
doi = "10.1093/ndt/gfi312",
language = "English",
volume = "21",
pages = "665--671",
journal = "Nephrology Dialysis Transplantation",
issn = "0931-0509",
publisher = "Oxford University Press",
number = "3",

}

TY - JOUR

T1 - Autosomal recessive Alport syndrome

T2 - An in-depth clinical and molecular analysis of five families

AU - Longo, Ilaria

AU - Scala, Elisa

AU - Mari, Francesca

AU - Caselli, Rossella

AU - Pescucci, Chiara

AU - Mencarelli, Maria Antonietta

AU - Speciale, Caterina

AU - Giani, Marisa

AU - Bresin, Elena

AU - Caringella, Domenica Angela

AU - Borochowitz, Zvi U.

AU - Siriwardena, Komudi

AU - Winship, Ingrid

AU - Renieri, Alessandra

AU - Meloni, Ilaria

PY - 2006/3

Y1 - 2006/3

N2 - Background. Alport syndrome (ATS) is a progressive inherited nephropathy characterized by irregular thinning, thickening and splitting of the glomerular basement membrane (GBM) often associated with hearing loss and ocular symptoms. ATS has been shown to be caused by COL4A5 mutations in its X-linked form and by COL4A3 and COL4A4 mutations in its autosomal forms. Methods. Five families with a suspicion of ATS were investigated both from a clinical and molecular point of view. COL4A3 and COL4A4 genes were analysed by DHPLC. Automated sequencing was performed to identify the underlying mutation. Results. Molecular analysis indicated that in all 5 cases the correct diagnosis was autosomal recessive ATS. In three families in which parental consanguinity clearly pinpointed to autosomal recessive ATS, we found COL4A4 homozygous mutations in two of them and COL4A3 homozygous mutation in the other one. In the remaining two families a differential diagnosis including X-linked ATS, autosomal recessive ATS and thin basement membrane nephropathy was considered. The molecular analysis demonstrated that the probands were genetic compounds for two different mutations in the COL4A4 gene pinpointing to the correct diagnosis of autosomal recessive ATS. Conclusions. A clinical evaluation of probands and their relatives of the five families carrying mutations in either the COL4A3 or the COL4A4 gene was carried out to underline the natural history of the autosomal recessive ATS. In addition, this paper stresses the complexity of the clinics and genetics of ATS and how a correct diagnosis is based on a combination of: (i) an in-depth clinical investigation; (ii) a detailed formal genetic analysis; (iii) a correct technical choice of the gene to be investigated; (iv) a correct technical choice of the family member to be included in the mutational screening. A correct diagnosis is the basis for an appropriate genetic counselling dealing with both the correct prognosis and the accurate recurrence risk for the patients and family members.

AB - Background. Alport syndrome (ATS) is a progressive inherited nephropathy characterized by irregular thinning, thickening and splitting of the glomerular basement membrane (GBM) often associated with hearing loss and ocular symptoms. ATS has been shown to be caused by COL4A5 mutations in its X-linked form and by COL4A3 and COL4A4 mutations in its autosomal forms. Methods. Five families with a suspicion of ATS were investigated both from a clinical and molecular point of view. COL4A3 and COL4A4 genes were analysed by DHPLC. Automated sequencing was performed to identify the underlying mutation. Results. Molecular analysis indicated that in all 5 cases the correct diagnosis was autosomal recessive ATS. In three families in which parental consanguinity clearly pinpointed to autosomal recessive ATS, we found COL4A4 homozygous mutations in two of them and COL4A3 homozygous mutation in the other one. In the remaining two families a differential diagnosis including X-linked ATS, autosomal recessive ATS and thin basement membrane nephropathy was considered. The molecular analysis demonstrated that the probands were genetic compounds for two different mutations in the COL4A4 gene pinpointing to the correct diagnosis of autosomal recessive ATS. Conclusions. A clinical evaluation of probands and their relatives of the five families carrying mutations in either the COL4A3 or the COL4A4 gene was carried out to underline the natural history of the autosomal recessive ATS. In addition, this paper stresses the complexity of the clinics and genetics of ATS and how a correct diagnosis is based on a combination of: (i) an in-depth clinical investigation; (ii) a detailed formal genetic analysis; (iii) a correct technical choice of the gene to be investigated; (iv) a correct technical choice of the family member to be included in the mutational screening. A correct diagnosis is the basis for an appropriate genetic counselling dealing with both the correct prognosis and the accurate recurrence risk for the patients and family members.

KW - Autosomal recessive ATS

KW - Collagen IV genes

KW - DHPLC

KW - Inherited nephropathy

KW - Phenotypic variability

UR - http://www.scopus.com/inward/record.url?scp=33644853600&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644853600&partnerID=8YFLogxK

U2 - 10.1093/ndt/gfi312

DO - 10.1093/ndt/gfi312

M3 - Article

C2 - 16338941

AN - SCOPUS:33644853600

VL - 21

SP - 665

EP - 671

JO - Nephrology Dialysis Transplantation

JF - Nephrology Dialysis Transplantation

SN - 0931-0509

IS - 3

ER -